A surprising discovery reveals that a gene previously thought to accelerate esophageal cancer actually helps protect against it initially. This pivotal study could lead to better prediction and ...

A genetic fault long believed to drive the development of esophageal cancer may in fact play a protective role early in the disease. This unexpected discovery could help doctors identify which ...

The FDA has granted priority review to an NDA for taletrectinib in the treatment of advanced ROS1-positive non–small cell ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Cancer in children and adolescents is rare. Nevertheless, malignant diseases are still one of the most common causes of death ...

USA News Group News Commentary ? Recent advancements in cancer treatment continue to underscore the transformative potential of innovative therapies to improve patient outcomes. A stage 4 breast ...

Cancer remission can be partial, complete, or spontaneous. For cancer to be in remission, a decrease in cancer signs for at least a month must be observed. Cancers in remission, however, may come ...

The KRAS gene is responsible for the production of a signaling protein called K-Ras. K-Ras tells cells how to divide, mature, and function. Dysregulation of this protein leads to uncontrolled cell ...

Many cancers, including PDAC, are driven by mutations in the RAS family of oncogenes – genes that, when altered, promote cancer. Researchers have long sought drugs that target the actions of mutant ...